Phase II Clinical Trial of RAB001 Officially Launched at Beijing Jishuitan Hospital and The Third Affiliated Hospital of Guangzhou University of Chinese Medicine!
Phase II Clinical Trial of RAB001 Officially Launched at Peking University Third Hospital!
First Subject Enrolled in Phase II Clinical Trial of World's First Osteonecrosis Drug RAB001!
Rabpharma Wins Silver Award at Greater Bay Area Postdoctoral Innovation Competition!
Groundbreaking: Rabpharma Officially Launches Phase II Clinical Trial of RAB001 at Shanghai Sixth People's Hospital!
